F. Hoffmann-La Roche Ltd.
🇨🇭Switzerland
Clinical Trials
1.1k
Active:1011
Completed:58
Trial Phases
4 Phases
Phase 1:705
Phase 2:4
Phase 3:18
+1 more phases
Drug Approvals
3
NMPA:3
Drug Approvals
Peginterferon alfa-2a Solution for Injection
- Product Name
- 派罗欣
- Approval Number
- 国药准字J20160076
- Approval Date
- Sep 27, 2016
NMPA
Peginterferon alfa-2a Solution for Injection
- Product Name
- 派罗欣
- Approval Number
- J20160076
- Approval Date
- Sep 27, 2016
NMPA
Clinical Trials
Distribution across different clinical trial phases (814 trials with phase data)• Click on a phase to view related trials
Phase 1
705 (86.6%)Not Applicable
86 (10.6%)Phase 3
18 (2.2%)Phase 2
4 (0.5%)phase_1_2
1 (0.1%)A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF OBINUTUZUMAB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
Phase 3
Recruiting
- Conditions
- M329 Systemic lupus erythematosus, unspecifiedSystemic lupus erythematosus, unspecifiedM329
- Last Posted Date
- 2024-08-20
- Lead Sponsor
- F. HOFFMANN-LA ROCHE LTD.
- Target Recruit Count
- 112
- Registration Number
- PER-021-21
News
No news found